E-LIB Suche - Ergebnisse für: Nagamatsu, Hiroaki

1

Ablation for Benign Liver Tumors: Current Concepts and Limi..:

Maruyama, Hitoshi ; Tobari, Maki ; Nagamatsu, Hiroaki..
Journal of Clinical and Translational Hepatology. 000 (2022) 000 - p. 000-000 , 2022

Link: https://doi.org/10.14218..

2

The Clinical Impact of Hepatic Arterial Infusion Chemothera..:

Iwamoto, Hideki ; Niizeki, Takashi ; Nagamatsu, Hiroaki...
Cancers. 14 (2022) 19 - p. 4873 , 2022

Link: https://doi.org/10.3390/..

3

Contrast-enhanced ultrasonography for the management of por..:

Maruyama, Hitoshi ; Tobari, Maki ; Nagamatsu, Hiroaki..
Frontiers in Medicine. 9 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

4

AI-Based Radiological Imaging for HCC: Current Status and F..:

Maruyama, Hitoshi ; Yamaguchi, Tadashi ; Nagamatsu, Hiroaki.
Diagnostics. 11 (2021) 2 - p. 292 , 2021

Link: https://doi.org/10.3390/..

5

Survival Benefit of Hepatic Arterial Infusion Chemotherapy ..:

Iwamoto, Hideki ; Niizeki, Takashi ; Nagamatsu, Hiroaki...
Cancers. 13 (2021) 4 - p. 646 , 2021

Link: https://doi.org/10.3390/..

6

Usefulness of a novel transarterial chemoinfusion plus exte..:

Shirono, Tomotake ; Koga, Hironori ; Niizeki, Takashi...
Cancer Reports. 5 (2021) 8 - p. , 2021

Link: https://doi.org/10.1002/..

7

APASL practical recommendations for the management of hepat..:

Shiina, Shuichiro ; Gani, Rino A. ; Yokosuka, Osamu...
Hepatology International. 14 (2020) 6 - p. 920-929 , 2020

Link: https://doi.org/10.1007/..

8

Incidence and hemodynamic feature of risky esophageal varic..:

Maruyama, Hitoshi ; Kobayashi, Kazufumi ; Kiyono, Soichiro...
International Journal of Medical Sciences. 16 (2019) 12 - p. 1614-1620 , 2019

Link: https://doi.org/10.7150/..

9

Immune-mediated Drug-induced Liver Injury Caused by Laninam..:

Kawaguchi, Toshihiro ; Arinaga-Hino, Teruko ; Shimizu, Motoki...
Internal Medicine. 58 (2019) 17 - p. 2501-2505 , 2019

Link: https://doi.org/10.2169/..

10

Efficacy and Safety of Deep Sedation in Percutaneous Radiof..:

Sato, Koki ; Taniki, Nobuhito ; Kanazawa, Ryo...
Advances in Therapy. 36 (2019) 2 - p. 344-354 , 2019

Link: https://doi.org/10.1007/..

11

Percutaneous Ablation for Hepatocellular Carcinoma: Compari..:

Shiina, Shuichiro ; Sato, Koki ; Tateishi, Ryosuke...
Canadian Journal of Gastroenterology and Hepatology. 2018 (2018) - p. 1-8 , 2018

Link: https://doi.org/10.1155/..

12

Transarterial chemoembolization with miriplatin vs. epirubi..:

Ikeda, Masafumi ; Kudo, Masatoshi ; Aikata, Hiroshi...
Journal of Gastroenterology. 53 (2017) 2 - p. 281-290 , 2017

Link: https://doi.org/10.1007/..

13

Alternative treatments in advanced hepatocellular carcinoma..:

Nakano, Masahito ; Tanaka, Masatoshi ; Kuromatsu, Ryoko...
Oncotarget. 7 (2016) 39 - p. 64400-64409 , 2016

Link: https://doi.org/10.18632..

14

Hepatic arterial infusion chemoembolization therapy for adv..:

Nagamatsu, Hiroaki ; Sumie, Shuji ; Niizeki, Takashi...
Cancer Chemotherapy and Pharmacology. 77 (2016) 2 - p. 243-250 , 2016

Link: https://doi.org/10.1007/..

15

Sorafenib for the treatment of advanced hepatocellular carc..:

Nakano, Masahito ; Tanaka, Masatoshi ; Kuromatsu, Ryoko...
Cancer Medicine. 4 (2015) 12 - p. 1836-1843 , 2015

Link: https://doi.org/10.1002/..